Physician

Samuel C. Kim, MD

According to 2025 Medicare claims, Samuel Kim, MD (NPI: 1720379100) practices ophthalmology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from San Bernardino, CA. This provider's primary affiliated billing organization is PACIFIC EYE INSTITUTE, A MEDICAL GROUP, INC. (NPI: 1962422709; TIN: 330303507) and primary practice location at 91786-4967.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 621 traditional Medicare patients, billed 33,308 HCPCS/CPT codes, and received $1,699,351 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,344 prescription claims across 405 beneficiaries totaling $105,104 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 7 records totaling $305. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $43,018 to $1,699,351. Similarly, Part D prescription costs have risen steadily, from $1,716 to $105,104. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$850K$1.7M2015 Medicare payment: $43,018 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $70,997 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $138,986 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $292,302 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $923,294 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,429,474 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,585,965 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,561,424 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,527,974 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,699,351 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015121497$43,018
2016307927$70,997
20173421,148$138,986
20183672,334$292,302
20197626,245$923,294
20206497,784$1,429,474
20216767,912$1,585,965
20227558,883$1,561,424
202365019,137$1,527,974
202462133,308$1,699,351

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$59K$118K2015 Drug cost: $1,716 (USD; Tot_Drug_Cst)2016 Drug cost: $4,388 (USD; Tot_Drug_Cst)2017 Drug cost: $18,369 (USD; Tot_Drug_Cst)2018 Drug cost: $34,962 (USD; Tot_Drug_Cst)2019 Drug cost: $65,324 (USD; Tot_Drug_Cst)2020 Drug cost: $77,159 (USD; Tot_Drug_Cst)2021 Drug cost: $72,548 (USD; Tot_Drug_Cst)2022 Drug cost: $117,601 (USD; Tot_Drug_Cst)2023 Drug cost: $92,001 (USD; Tot_Drug_Cst)2024 Drug cost: $105,104 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151551$1,716
201640101$4,388
201785218$18,369
2018139437$34,962
20193151,096$65,324
20204251,581$77,159
20213521,395$72,548
20224001,423$117,601
20233581,308$92,001
20244051,344$105,104

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye246994$98
92014Established patient complete exam of visual system6001,459$93
J9035Injection, bevacizumab, 10 mg91336$57
92134Imaging of retina4871,286$32
92250Photography of the retina236373$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast15870$19,235
RestasisCyclosporine17810$16,080
RhopressaNetarsudil Mesylate401,164$12,362
Prednisolone AcetatePrednisolone Acetate2007,395$7,670
RocklatanNetarsudil Mesylat/Latanoprost12554$6,817

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$305Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Samuel C. Kim, MD?

Tedicare shows public-source Medicare data for Samuel C. Kim, MD (NPI 1720379100), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel C. Kim, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Samuel C. Kim, MD?

Samuel C. Kim, MD is linked to PACIFIC EYE INSTITUTE, A MEDICAL GROUP, INC. (billing NPI 1962422709) in the available physician profile data.

Does Samuel C. Kim, MD have Open Payments data?

Samuel C. Kim, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.